In this issue:
Ustekinumab: no effect upon BMI in psoriasis
Topical therapies for plaque psoriasis
Long-term safety of ustekinumab
Treating IFN-α-induced psoriasis
Guidance on moderate-to-severe plaque psoriasis
Topical tofacitinib for psoriasis
Psoriasis and parkinsonism anti-IL-12/23 agents and major CV events
Screen psoriasis patients for metabolic syndrome?
Eye involvement in psoriasis
Please login below to download this issue (PDF)